NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity.
about
From Immunologically Archaic to Neoteric Glycovaccines.Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.Expanding the biomass derived chemical space.Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins.Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models.The Conventional Nature of Non-MHC-Restricted T Cells.
P2860
Q30238724-202B67F9-6773-4661-A315-B144531587E9Q39049093-9C4AA801-D6B9-4626-B95A-FE68E6A322FAQ41671146-839E666D-D9AD-434F-B351-6750A3942D2CQ47144502-7804578A-96E5-45B1-83FB-EC1D3A8CBB57Q47590580-D1C679A9-D31F-4122-9765-39564E15B748Q50234200-94954FC7-A5B9-4DC7-A3F5-660E0F6AFF78Q55399719-6804E98B-1ACB-473E-AD50-4DD6DF4F10C9
P2860
NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity.
@en
type
label
NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity.
@en
prefLabel
NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity.
@en
P2093
P2860
P50
P356
P1433
P1476
NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity.
@en
P2093
Astrid Authier-Hall
Ching-Wen Tang
Colin M Hayman
David S Larsen
Gene W Swinerd
Paul Harris
P2860
P304
P356
10.1039/C4SC03599B
P50
P577
2015-06-25T00:00:00Z